The flowers of Chrysanthemum morifolium RAMAT. and related chrysanthemum plants (Asteraceae) are used as a Chinese natural medicine. Florists Chrysanthemum Flower (Ju Hua) is prescribed for anti-inflammatory, analgesic, and antipyretic purposes and for the treatment of eye disease in Chinese traditional preparations. 1) In the course of our studies on bioactive principles of natural medicines and medicinal foodstuffs, we found that the triterpene alcohols isolated from the non-saponifiable lipid (NSL) fraction of the extract of chrysanthemum (C. morifolium RAMAT. var. sinense MAKINO forma esculentum MAKINO; Japanese name: Ryourigiku) and other Asteraceae plants (pot marigold, cosmos, sunflower, burdock, etc.) possess remarkable anti-inflammatory activity on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in mice, [2] [3] [4] [5] inhibitory effects on trypsin and chymotrypsin, 6) anti-tumor promoting effects, [7] [8] [9] and cytotoxic activity against human cancer cell lines. 7) Various types of triterpenoids from plants have recently been reported to exhibit antitubercular activity. 10, 11) In this paper, we describe the antitubercular activity against Mycobacterium tuberculosis of twenty-nine 3-hydroxy triterpenoids: twentyeight (1-16, 18-29) were isolated from the NSL fraction of the extract of chrysanthemum flowers and one (17) was chemically derived from compound 16.
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MATERIALS AND METHODS
Chemicals Twenty-seven triterpenoids (1-16, 18-26, 28, 29) (Chart 1) were isolated from the NSL fraction of the methanol extract of chrysanthemum flowers. 2, 3, 5) Triterpenoid 27, which had previously been isolated from the extract of sunflower pollen, 12) was isolated from the NSL fraction of the methanol extract of chrysanthemum flower, 13) and triterpenoid 17 was prepared from 16 by oxidation with CrO 3 -pyridine followed by NaBH 4 reduction of the oxidation product. 14) Determination of Antitubercular Activity Antitubercular activity of compounds in DMSO was determined against Mycobacterium tuberculosis H 37 Rv (ATCC 27294) in Middlebrook 7H12 medium using the Microplate Alamar Blue Assay (MABA) as previously described.
15) The MIC is defined as the lowest concentration effecting a reduction in fluorescence of 90% relative to controls.
Cytotoxicity Assay Toxicity against Vero cells (ATCC CCL-81) was determined as described earlier. 16) After 72 h exposure, cell viability was measured using the CellTiter 96 aqueous non-radioactive cell proliferation assay. The IC 50 is defined as the reciprocal dilution resulting in 50% inhibition of the Vero cells.
RESULTS AND DISCUSSION
The MIC values of 1-29 against M. tuberculosis are shown in Table 1 . Among the compounds tested, fifteen of them: five taraxastanes (2, 4-7), two oleananes (9, 11), two ursanes (13, 15), two lupanes (17, 18), two cycloartanes (22, 24), one tirucallane (27), and one dammarane (29), exhibited activity with MIC values of 4-64 mg/ml, among which maniladiol (9; MIC 4 mg/ml) and 3-epilupeol (17; 4 mg/ml) followed by 4,5a-epoxyhelianol (27; 6 mg/ml) showed the most potent activity, although still being an order of magnitude less potent than the first-line antitubercular drug, rifampin (Table 1) .
There was no apparent correlation between triterpenoid structural type (taraxastane, oleanane, ursane, lupane, taraxerane, cycloartane, tirucallane, and dammarane) and anti-tubercular activity, which was consistent with previous observations. 10, 11) From the limited data set, it appears that a hydroxyl group at C-16b gives rise to higher activity for the pentacyclic 3b-hydroxy triterpenoids (2/1, 9/8, 18/16) although a reverse correlation was observed between the set of ursanes, 14/13. Moreover, some higher activity was observed for three other 3b,16b-dihydroxy triterpenoids, 4, 5, and 7 (MIC 16-32 mg/ml), all of which are the taraxastane-type. Further hydroxylation at C-22a (3/2) or at C-28 (11/9, 19/18) decreased the activity. Conversion of the stereochem- istry of the hydroxyl group at C-3 from b to a significantly increased the activity for the lupane-type compounds 16 (MICϾ64 mg/ml) and 17 (4 mg/ml). A similar tendency was also reported for the set of C-3 epimers of oleanane, oleanolic acid (3a-hydroxy) and 3-epioleanolic acid (3a-hydroxy). 11) This is not, however, the general feature for 3-hydroxy triterpenoids since betulinic acid with its b-hydroxyl group at C-3 is more active than its C-3 epimer, epi-betulinic acid. 10, 11) A significant increase in activity was observed by epoxidation at C-4,5a (27) for the 3,4-seco-3-hydroxy triterpenoid 26. The essential role of an epoxide ring for in vitro antituberculosis activity was observed also in the cycloartane triterpenoids where (24R)-24,25-epoxycycloartan-3-one and (24R)-24,25-epoxycycloartan-3b-ol showed high activity with MICs of 8 mg/ml. 11, 16) Compound 17, one of the most active compounds in this study, was submitted to the further evaluation of cytotoxicity against Vero cells. The IC 50 value over 62.5 mg/ml for compound 17 suggests some degree of selective toxicity for M. tuberculosis.
Antitubercular Activity of Triterpenoids from Asteraceae Flowers
The NSL fractions of the extracts of chrysanthemum flowers and other Asteraceae plant flowers (e.g., Calendula officinalis, Helianthus annuus, H. debilis, Matricalia matricarioides, Taraxacum officinale, and T. platycarpum) contain two taraxastanes, 2 and 7, and one oleanane, 9, as common and, in most cases, as the dominant triterpenoid constituents. 3) Since these compounds exhibited high activity against M. tuberculosis, the extracts of chrysanthemum and the other Asteraceae flowers might be of value from the viewpoint of antituberculosis.
